Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361306 | PMC |
http://dx.doi.org/10.1002/jmv.26278 | DOI Listing |
PLoS One
January 2025
Federal University of Health Sciences of Porto Alegre, Porto Alegre, RS, Brazil.
Nasopharyngeal transmission of Streptococcus pneumoniae is a prerequisite for the development of pneumococcal diseases. Previous studies have reported a relationship between respiratory viruses and S. pneumoniae infections.
View Article and Find Full Text PDFInfect Drug Resist
December 2024
Dunarea de Jos" University of Galati, Faculty of Medicine and Pharmacy, Galati, Romania.
Streptococcus pneumoniae is the main pathogen that plays a dual role, on the one hand as an asymptomatic carrier in the nasopharyngeal mucosa and on the other hand directly responsible for triggering invasive pneumococcal infections with various important localizations, especially in the pediatric population. Thus, invasive pneumococcal infections represent one of the main causes of mortality and morbidity in children under 5 years of age. Immunization is a key preventive measure against these infections.
View Article and Find Full Text PDFPLoS One
December 2024
Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Esplugues, Barcelona, Spain.
Background: Despite growing evidence of reduced invasive and non-invasive pneumococcal disease attributed to public health measures against the COVID-19 pandemic, the effect of these measures on pneumococcal carriage remains unclear. This study aimed to assess pneumococcal nasopharyngeal carriage among children and adults self-confined at home during the COVID-19 national lockdown in Spain while identifying predictors of pneumococcal carriage in children.
Methods: Household study conducted across the metropolitan area of Barcelona (Spain) between April-June 2020.
Pediatr Pulmonol
January 2025
Institute for Biomedicine and Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Cell Host Microbe
September 2024
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, UK; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK. Electronic address:
Epidemiological studies report the impact of co-infection with pneumococcus and respiratory viruses upon disease rates and outcomes, but their effect on pneumococcal carriage acquisition and bacterial load is scarcely described. Here, we assess this by combining natural viral infection with controlled human pneumococcal infection in 581 healthy adults screened for upper respiratory tract viral infection before intranasal pneumococcal challenge. Across all adults, respiratory syncytial virus (RSV) and rhinovirus asymptomatic infection confer a substantial increase in secondary infection with pneumococcus.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!